Last 12 months
Inside the activity.
1 purchase rows · 150 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 56 |
| May 2026 | 0 | 12 |
| Jun 2026 | 1 | 15 |
| Jul 2026 | 0 | 18 |
| Aug 2026 | 0 | 20 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 13 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 20, 2026 20:02 UTC |
Xu ZhenyuChief Scientific Officer
|
SaleOrdinary Shares | 608 | $4.60 | $2,797.71 |
DisclosureSEC source: 0001840706-26-000200 · wk-form4_1779307372.xml · nonDerivative · entry 1 Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 626,280 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:02 UTC |
Valente ManuelaChief People Officer
|
SaleOrdinary Shares | 380 | $4.60 | $1,747.43 |
DisclosureSEC source: 0001840706-26-000196 · wk-form4_1779307346.xml · nonDerivative · entry 1 Valente Manuela · CIK 0002009280 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,691 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.65, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:02 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 4,486 | $4.60 | $20,657.58 |
DisclosureSEC source: 0001840706-26-000199 · wk-form4_1779307366.xml · nonDerivative · entry 1 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,629,495 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.71, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:02 UTC |
Van Well DaanChief Legal Officer
|
SaleOrdinary Shares | 684 | $4.60 | $3,149.27 |
DisclosureSEC source: 0001840706-26-000197 · wk-form4_1779307352.xml · nonDerivative · entry 1 Van Well Daan · CIK 0002006414 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 345,052 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:03 UTC |
Muken RossPresident
|
SaleOrdinary Shares | 761 | $4.60 | $3,501.06 |
DisclosureSEC source: 0001840706-26-000201 · wk-form4_1779307378.xml · nonDerivative · entry 1 Muken Ross · CIK 0002005463 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 680,911 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:02 UTC |
Puylaert KevinChief Sales Officer
|
SaleOrdinary Shares | 33 | $4.54 | $149.90 |
DisclosureSEC source: 0001840706-26-000195 · wk-form4_1779307340.xml · nonDerivative · entry 1 Puylaert Kevin · CIK 0002119354 · Chief Sales Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,164 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on May 18, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades. Read SEC document |
| May 13, 2026 Filed May 14, 2026 20:01 UTC |
Xu ZhenyuChief Scientific Officer
|
SaleOrdinary Shares | 4,000 | $4.54 | $18,168.40 |
DisclosureSEC source: 0001840706-26-000186 · wk-form4_1778788910.xml · nonDerivative · entry 1 Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 626,888 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.48 to $4.65, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 12, 2026 Filed May 13, 2026 20:01 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 5,000 | $4.67 | $23,344.50 |
DisclosureSEC source: 0001840706-26-000183 · wk-form4_1778702482.xml · nonDerivative · entry 1 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 256,388 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.56 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 12, 2026 Filed May 13, 2026 20:01 UTC |
HIBBS KATHY LDirector
|
SaleOrdinary Shares | 7,508 | $4.67 | $35,036.83 |
DisclosureSEC source: 0001840706-26-000184 · wk-form4_1778702489.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,768 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 12, 2026 20:01 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 8,500 | $5.09 | $43,241.20 |
DisclosureSEC source: 0001840706-26-000180 · wk-form4_1778616075.xml · nonDerivative · entry 1 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,633,981 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.72 to $5.49, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2026 Filed Apr 28, 2026 20:03 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 5,000 | $4.82 | $24,089.00 |
DisclosureSEC source: 0001840706-26-000176 · wk-form4_1777406606.xml · nonDerivative · entry 1 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 261,388 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.75 to $4.89, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:04 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 608 | $5.20 | $3,161.72 |
DisclosureSEC source: 0001840706-26-000170 · wk-form4_1776801867.xml · nonDerivative · entry 1 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 266,388 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:04 UTC |
Valente ManuelaChief People Officer
|
SaleOrdinary Shares | 380 | $5.20 | $1,977.18 |
DisclosureSEC source: 0001840706-26-000174 · wk-form4_1776801885.xml · nonDerivative · entry 1 Valente Manuela · CIK 0002009280 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,071 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:04 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 4,486 | $5.21 | $23,349.63 |
DisclosureSEC source: 0001840706-26-000171 · wk-form4_1776801871.xml · nonDerivative · entry 1 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,642,481 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.08 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:04 UTC |
Xu ZhenyuChief Scientific Officer
|
SaleOrdinary Shares | 608 | $5.21 | $3,164.82 |
DisclosureSEC source: 0001840706-26-000173 · wk-form4_1776801880.xml · nonDerivative · entry 1 Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 630,888 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:04 UTC |
Van Well DaanChief Legal Officer
|
SaleOrdinary Shares | 684 | $5.20 | $3,554.27 |
DisclosureSEC source: 0001840706-26-000172 · wk-form4_1776801876.xml · nonDerivative · entry 1 Van Well Daan · CIK 0002006414 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 345,736 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:04 UTC |
Muken RossPresident
|
SaleOrdinary Shares | 760 | $5.20 | $3,954.96 |
DisclosureSEC source: 0001840706-26-000169 · wk-form4_1776801861.xml · nonDerivative · entry 1 Muken Ross · CIK 0002005463 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 681,672 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:04 UTC |
Puylaert KevinChief Sales Officer
|
SaleOrdinary Shares | 33 | $5.08 | $167.69 |
DisclosureSEC source: 0001840706-26-000168 · wk-form4_1776801856.xml · nonDerivative · entry 1 Puylaert Kevin · CIK 0002119354 · Chief Sales Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,197 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on April 18, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 20:03 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 17,473 | $5.00 | $87,401.69 |
DisclosureSEC source: 0001840706-26-000159 · wk-form4_1776369811.xml · nonDerivative · entry 2 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,646,967 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.90 to $5.08, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 20:03 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 1,600 | $4.96 | $7,932.96 |
DisclosureSEC source: 0001840706-26-000158 · wk-form4_1776369806.xml · nonDerivative · entry 1 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 266,996 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $5.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 20:03 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 43,129 | $4.96 | $213,833.58 |
DisclosureSEC source: 0001840706-26-000159 · wk-form4_1776369811.xml · nonDerivative · entry 1 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,664,440 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.73 to $5.18, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 20:03 UTC |
Xu ZhenyuChief Scientific Officer
|
SaleOrdinary Shares | 600 | $4.97 | $2,979.78 |
DisclosureSEC source: 0001840706-26-000160 · wk-form4_1776369817.xml · nonDerivative · entry 1 Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 631,496 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.82 to $5.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 20:03 UTC |
Muken RossPresident
|
SaleOrdinary Shares | 2,800 | $4.96 | $13,887.16 |
DisclosureSEC source: 0001840706-26-000157 · wk-form4_1776369800.xml · nonDerivative · entry 1 Muken Ross · CIK 0002005463 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 682,432 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.75 to $5.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 20:01 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 3,400 | $4.76 | $16,198.28 |
DisclosureSEC source: 0001840706-26-000148 · wk-form4_1776196912.xml · nonDerivative · entry 3 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,596 F4 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.62 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 20:01 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 1,000 | $4.76 | $4,764.20 |
DisclosureSEC source: 0001840706-26-000148 · wk-form4_1776196912.xml · nonDerivative · entry 2 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,996 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.62 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 20:02 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 4,399 | $4.76 | $20,957.28 |
DisclosureSEC source: 0001840706-26-000150 · wk-form4_1776196923.xml · nonDerivative · entry 3 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,707,569 F3 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.64 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 20:02 UTC |
Xu ZhenyuChief Scientific Officer
|
SaleOrdinary Shares | 3,400 | $4.76 | $16,196.58 |
DisclosureSEC source: 0001840706-26-000151 · wk-form4_1776196927.xml · nonDerivative · entry 3 Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 632,096 F4 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 20:02 UTC |
Xu ZhenyuChief Scientific Officer
|
SaleOrdinary Shares | 1,014 | $4.76 | $4,830.39 |
DisclosureSEC source: 0001840706-26-000151 · wk-form4_1776196927.xml · nonDerivative · entry 2 Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 635,496 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 20:02 UTC |
Muken RossPresident
|
SaleOrdinary Shares | 4,442 | $4.77 | $21,166.13 |
DisclosureSEC source: 0001840706-26-000149 · wk-form4_1776196918.xml · nonDerivative · entry 2 Muken Ross · CIK 0002005463 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 685,232 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 (c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.62 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 20:01 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 3,725 | $4.68 | $17,441.20 |
DisclosureSEC source: 0001840706-26-000148 · wk-form4_1776196912.xml · nonDerivative · entry 1 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,996 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 20:02 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 3,732 | $4.72 | $17,607.58 |
DisclosureSEC source: 0001840706-26-000150 · wk-form4_1776196923.xml · nonDerivative · entry 2 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,711,968 F3 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.60 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 20:02 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 8,500 | $4.72 | $40,103.00 |
DisclosureSEC source: 0001840706-26-000150 · wk-form4_1776196923.xml · nonDerivative · entry 1 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,715,700 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.60 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 20:02 UTC |
Xu ZhenyuChief Scientific Officer
|
SaleOrdinary Shares | 3,706 | $4.68 | $17,347.04 |
DisclosureSEC source: 0001840706-26-000151 · wk-form4_1776196927.xml · nonDerivative · entry 1 Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 636,510 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 20:02 UTC |
Van Well DaanChief Legal Officer
|
SaleOrdinary Shares | 2,400 | $4.67 | $11,201.28 |
DisclosureSEC source: 0001840706-26-000152 · wk-form4_1776196932.xml · nonDerivative · entry 1 Van Well Daan · CIK 0002006414 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 346,420 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 20:02 UTC |
Muken RossPresident
|
SaleOrdinary Shares | 3,687 | $4.69 | $17,278.76 |
DisclosureSEC source: 0001840706-26-000149 · wk-form4_1776196918.xml · nonDerivative · entry 1 Muken Ross · CIK 0002005463 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 689,674 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 (c) trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2026 Filed Apr 10, 2026 20:02 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 1,931 | $4.74 | $9,151.59 |
DisclosureSEC source: 0001840706-26-000139 · wk-form4_1775851351.xml · nonDerivative · entry 2 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,721 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.655 to $4.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2026 Filed Apr 10, 2026 20:02 UTC |
Xu ZhenyuChief Scientific Officer
|
SaleOrdinary Shares | 1,936 | $4.74 | $9,176.45 |
DisclosureSEC source: 0001840706-26-000140 · wk-form4_1775851359.xml · nonDerivative · entry 2 Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 640,216 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2026 Filed Apr 10, 2026 20:02 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 1,950 | $4.74 | $9,243.78 |
DisclosureSEC source: 0001840706-26-000142 · wk-form4_1775851376.xml · nonDerivative · entry 2 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,724,200 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.665 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2026 Filed Apr 10, 2026 20:02 UTC |
Van Well DaanChief Legal Officer
|
SaleOrdinary Shares | 1,988 | $4.74 | $9,424.31 |
DisclosureSEC source: 0001840706-26-000137 · wk-form4_1775851332.xml · nonDerivative · entry 2 Van Well Daan · CIK 0002006414 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 348,820 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · balance_after: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 09, 2026 Filed Apr 10, 2026 20:02 UTC |
Muken RossPresident
|
SaleOrdinary Shares | 1,950 | $4.74 | $9,238.91 |
DisclosureSEC source: 0001840706-26-000141 · wk-form4_1775851367.xml · nonDerivative · entry 2 Muken Ross · CIK 0002005463 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 693,361 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.665 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:02 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 2,800 | $4.84 | $13,543.60 |
DisclosureSEC source: 0001840706-26-000139 · wk-form4_1775851351.xml · nonDerivative · entry 1 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,652 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:02 UTC |
Valente ManuelaChief People Officer
|
SaleOrdinary Shares | 3,824 | $4.85 | $18,542.58 |
DisclosureSEC source: 0001840706-26-000138 · wk-form4_1775851340.xml · nonDerivative · entry 1 Valente Manuela · CIK 0002009280 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,451 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:02 UTC |
Xu ZhenyuChief Scientific Officer
|
SaleOrdinary Shares | 2,800 | $4.84 | $13,549.20 |
DisclosureSEC source: 0001840706-26-000140 · wk-form4_1775851359.xml · nonDerivative · entry 1 Xu Zhenyu · CIK 0002006362 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 642,152 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: prices ranging from $4.79 to $4.92, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:02 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 2,800 | $4.84 | $13,553.12 |
DisclosureSEC source: 0001840706-26-000142 · wk-form4_1775851376.xml · nonDerivative · entry 1 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,726,150 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:02 UTC |
Van Well DaanChief Legal Officer
|
SaleOrdinary Shares | 2,861 | $4.85 | $13,862.12 |
DisclosureSEC source: 0001840706-26-000137 · wk-form4_1775851332.xml · nonDerivative · entry 1 Van Well Daan · CIK 0002006414 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350,808 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.94, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:02 UTC |
Muken RossPresident
|
SaleOrdinary Shares | 2,786 | $4.84 | $13,488.14 |
DisclosureSEC source: 0001840706-26-000141 · wk-form4_1775851367.xml · nonDerivative · entry 1 Muken Ross · CIK 0002005463 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 695,311 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.77 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:02 UTC |
CARDOZA GEORGEChief Financial Officer
|
SaleOrdinary Shares | 1,403 | $4.85 | $6,800.62 |
DisclosureSEC source: 0001840706-26-000136 · wk-form4_1775851324.xml · nonDerivative · entry 1 CARDOZA GEORGE · CIK 0001518734 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 291,458 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.79 to $4.93, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 20:05 UTC |
Menu PhilippeChief Medical Officer
|
SaleOrdinary Shares | 2,400 | $4.87 | $11,676.72 |
DisclosureSEC source: 0001840706-26-000128 · wk-form4_1775678710.xml · nonDerivative · entry 2 Menu Philippe · CIK 0002014308 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 281,452 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · balance_after: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 20:04 UTC |
Camblong JurgiDirector · Chief Executive Officer
|
SaleOrdinary Shares | 2,500 | $4.86 | $12,154.75 |
DisclosureSEC source: 0001840706-26-000124 · wk-form4_1775678672.xml · nonDerivative · entry 2 Camblong Jurgi · CIK 0002007050 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,728,950 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.69 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 20:04 UTC |
Valente ManuelaChief People Officer
|
SaleOrdinary Shares | 2,376 | $4.87 | $11,565.89 |
DisclosureSEC source: 0001840706-26-000122 · wk-form4_1775678653.xml · nonDerivative · entry 2 Valente Manuela · CIK 0002009280 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,275 F1 · shares: Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.68 to $5.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.